India hosts more active pharmaceutical ingredient (API) manufacturing sites that are compliant with the U.S. Food and Drug Administration than any country outside the U.S., and it produces more ...

HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ — The pharmaceutical industry is undergoing a period of rapid evolution, driven by global health ...

QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...

Agno Pharma Acquires Actylis’s CDMO Manufacturing Asset, the Legacy Cascade Chemistry Business based in Eugene, Oregon, Strengthening Agno’s US cGMP API Development and Manufacturing Capabilities Agno ...

Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active pharmaceutical ingredients (APIs) and critical GMP intermediates announced the ...

Oil industry executives have voiced that reviving Venezuela's oil production will be a long and costly process. Companies will need stable, legally defined frameworks, security for investments, and ...

A joint pilot program between the American CDMO Phlow and biotechnology company Enveda is advancing AI-driven active pharmaceutical ingredient (API) manufacturing process development. The companies ...

Intel Corp. today showcased a new class of Intel Core Ultra X9 and X7 processors, the first new chips built on its most advanced 18A manufacturing process. Announced at the CES electronics trade show ...

Diversifying its supply base and reducing production in China were part of Lovesac's four-pronged tariff strategy launched in April. The revamped Sactionals line serves as the basis for a new ...

President Donald Trump has pledged that his tariffs will bring manufacturing jobs back to America and make America a net exporter again. So far, the exact opposite has happened: Manufacturing jobs ...